SLC1A5 and neoplasm: Intriguingly, although the GSE62452 cohort revealed that there was no significant difference in SLC1A5 expression between normal and tumor samples (Figure 2M), high SLC1A5 expression resulted in poor prognosis (HR = 1.83, P = 0.043), and achieved a predicting accuracy similar with that in TCGA cohort (AUC = 0.668) (Figures 4E,H).